Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
Infect Control Hosp Epidemiol ; 38(2): 186-188, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27852357

RESUMO

BACKGROUND Catheter-associated urinary tract infections (CAUTIs) are among the most common hospital-acquired infections (HAIs). Reducing CAUTI rates has become a major focus of attention due to increasing public health concerns and reimbursement implications. OBJECTIVE To implement and describe a multifaceted intervention to decrease CAUTIs in our ICUs with an emphasis on indications for obtaining a urine culture. METHODS A project team composed of all critical care disciplines was assembled to address an institutional goal of decreasing CAUTIs. Interventions implemented between year 1 and year 2 included protocols recommended by the Centers for Disease Control and Prevention for placement, maintenance, and removal of catheters. Leaders from all critical care disciplines agreed to align routine culturing practice with American College of Critical Care Medicine (ACCCM) and Infectious Disease Society of America (IDSA) guidelines for evaluating a fever in a critically ill patient. Surveillance data for CAUTI and hospital-acquired bloodstream infection (HABSI) were recorded prospectively according to National Healthcare Safety Network (NHSN) protocols. Device utilization ratios (DURs), rates of CAUTI, HABSI, and urine cultures were calculated and compared. RESULTS The CAUTI rate decreased from 3.0 per 1,000 catheter days in 2013 to 1.9 in 2014. The DUR was 0.7 in 2013 and 0.68 in 2014. The HABSI rates per 1,000 patient days decreased from 2.8 in 2013 to 2.4 in 2014. CONCLUSIONS Effectively reducing ICU CAUTI rates requires a multifaceted and collaborative approach; stewardship of culturing was a key and safe component of our successful reduction efforts. Infect Control Hosp Epidemiol 2017;38:186-188.


Assuntos
Infecções Relacionadas a Cateter/epidemiologia , Infecção Hospitalar/prevenção & controle , Controle de Infecções/métodos , Unidades de Terapia Intensiva , Infecções Urinárias/epidemiologia , Gestão de Antimicrobianos/estatística & dados numéricos , Humanos , Ohio/epidemiologia , Urina/microbiologia
3.
J Clin Anesth ; 27(7): 602-5, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26260647

RESUMO

A 62-year-old woman with prosthetic mitral valve was admitted for explant of an infected prosthetic knee. Perioperatively, she was bridged with heparin and started on empiric vancomycin and piperacillin-tazobactam. Platelet counts dropped precipitously within 2 days reaching a nadir of 6000/µL, without any bleeding. Decline persisted despite substituting heparin with bivalirudin. Antiplatelet factor 4 and anti-PLA1 antigen were negative. Schistocytes were absent. Antibiotics were substituted with daptomycin for suspected drug-induced thrombocytopenia. Pulse dose of intravenous immunoglobulin was initiated with rapid normalization of platelet count. She tested positive for IgG antiplatelet antibodies to vancomycin and piperacillin-tazobactam thereby confirming the diagnosis. Drug-induced immune-mediated thrombocytopenia is an underrecognized cause of thrombocytopenia in the intensive care units. Clinicians should be cognizant of this entity, and a definitive diagnosis should be sought if feasible.


Assuntos
Ácido Penicilânico/análogos & derivados , Púrpura Trombocitopênica Idiopática/induzido quimicamente , Vancomicina/efeitos adversos , Remoção de Dispositivo , Feminino , Humanos , Imunoglobulina G/imunologia , Unidades de Terapia Intensiva , Pessoa de Meia-Idade , Ácido Penicilânico/administração & dosagem , Ácido Penicilânico/efeitos adversos , Piperacilina/administração & dosagem , Piperacilina/efeitos adversos , Combinação Piperacilina e Tazobactam , Infecções Relacionadas à Prótese/cirurgia , Púrpura Trombocitopênica Idiopática/diagnóstico , Púrpura Trombocitopênica Idiopática/imunologia , Vancomicina/administração & dosagem
4.
J Bronchology Interv Pulmonol ; 22(3): 251-8, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26165897

RESUMO

Pulmonary alveolar proteinosis is a disease caused by increased accumulation and impaired clearance of surfactant by alveolar macrophages. This narrative review summarizes the role of therapeutic whole-lung lavage in the management of pulmonary alveolar proteinosis. We describe the preprocedural evaluation, indications, and anesthetic considerations, along with step-by step technical aspects of the procedure, postoperative recovery, potential complications, and long-term outcomes.


Assuntos
Lavagem Broncoalveolar/métodos , Doenças Pulmonares Intersticiais/terapia , Proteinose Alveolar Pulmonar/terapia , Lavagem Broncoalveolar/efeitos adversos , Seguimentos , Hospitalização , Humanos , Doenças Pulmonares Intersticiais/fisiopatologia , Salas Cirúrgicas , Proteinose Alveolar Pulmonar/fisiopatologia
6.
J Clin Anesth ; 26(8): 693-6, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25439398

RESUMO

Routine chest roentgenogram to confirm catheter placement in a postsurgical patient showed a left-sided internal jugular central venous catheter that did not appear to cross the midline. Arterial blood gas samples showed greater oxygenation from the central catheter as compared with the peripheral arterial sample. However, a transduced waveform showed a venous tracing and pressure. Computed tomographic scan of the thorax without intravenous contrast showed a partial anomalous pulmonary venous connection with drainage of the left upper lobe pulmonary vein into the innominate vein.


Assuntos
Cateterismo Venoso Central , Veias Pulmonares/anormalidades , Malformações Vasculares/diagnóstico , Idoso , Gasometria , Cuidados Críticos , Humanos , Achados Incidentais , Masculino , Oxigênio/metabolismo , Tomografia Computadorizada por Raios X , Malformações Vasculares/patologia
7.
J Clin Anesth ; 26(3): 231-4, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24793702

RESUMO

Patients receiving preoperative lithium therapy for bipolar disorder may present unique challenges in the perioperative period and during critical illness. Two cases of critically ill patients who developed lithium-induced adverse reactions in the perioperative period due to the low therapeutic index are reported.


Assuntos
Antimaníacos/efeitos adversos , Transtorno Bipolar/tratamento farmacológico , Compostos de Lítio/efeitos adversos , Antimaníacos/administração & dosagem , Estado Terminal , Feminino , Humanos , Compostos de Lítio/administração & dosagem , Pessoa de Meia-Idade , Período Pós-Operatório
15.
Neurocrit Care ; 1(3): 367-9, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-16174936

RESUMO

The authors report the first case of propofol use for the control of non-epileptic involuntary movements in a patient with postviral encephalitis. The withdrawal from propofol was associated with re-emergence of involuntary movements. The patient was maintained on propofol infusion for 6 months while a series of medications were used in an attempt to control the movements. The movements were finally controlled with high doses of phenobarbital, diazepam, and olanzapine, and the propofol was slowly weaned.


Assuntos
Anticonvulsivantes/uso terapêutico , Discinesias/tratamento farmacológico , Propofol/uso terapêutico , Adulto , Discinesias/etiologia , Encefalite Viral/complicações , Feminino , Humanos
16.
Infect Control Hosp Epidemiol ; 24(5): 347-50, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12785408

RESUMO

BACKGROUND: Patients with penicillin allergy admitted to the intensive care unit (ICU) frequently receive non-beta-lactam antimicrobials for the treatment of infection. The use of these antimicrobials, more commonly vancomycin and fluoroquinolones, is associated with the emergence of multidrug-resistant infections. The penicillin skin test (PST) can help detect patients at risk of developing an immediate allergic reaction to penicillin and those patients with a negative PST may be able to use a penicillin antibiotic safely. METHODS: We determined the incidence of true penicillin allergy, the percentage of patients changed to a beta-lactam antimicrobial when the test was negative, the safety of the test, and the safety of administration of beta-lactam antimicrobials in patients with a negative test. Skin testing was performed using standard methodology. RESULTS: One hundred patients admitted to 4 ICUs were prospectively studied; 58 of them were male. The mean age was 63 years. Ninety-six patients had the PST: one was positive (1.04%), 10 (10.4%) were nondiagnostic, and 85 (88.5%) were negative. Of the 38 patients who received antimicrobials for therapeutic reasons, 31(81.5%) had the antibiotic changed to a beta-lactam antimicrobial after a negative reading versus 7 patients of the 57 (12%) who had received a prophylactic antimicrobial (P < .001). No adverse effects were reported after the PST or after antimicrobial administration. CONCLUSIONS: The PST is a safe, reliable, and effective strategy to reduce the use of non-beta-lactam antimicrobials in patients who are labeled as penicillin allergic and admitted to the ICU.


Assuntos
Antibacterianos/uso terapêutico , Hipersensibilidade a Drogas/diagnóstico , Unidades de Terapia Intensiva , Penicilinas/efeitos adversos , Testes Cutâneos , Resistência a Múltiplos Medicamentos , Humanos , Lactamas , Ohio , Estudos Prospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA